Irreversible Pulpitis Completed Phase 3 Trials for Lidocaine (DB00281)

IndicationStatusPhase
DBCOND0047915 (Irreversible Pulpitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT028072984% Articaine and 2% Lidocaine by Intraligamentary Technique in Irreversible PulpitisTreatment